Cell Surface Markers in Multiple Myeloma
- 1 July 1994
- journal article
- research article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 69 (7), 684-690
- https://doi.org/10.1016/s0025-6196(12)61350-0
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Biology and treatment of multiple myelomaBlood Reviews, 1993
- Lymphoid subsets and prognostic factors in multiple myelomaBritish Journal of Haematology, 1992
- Markers of Multiple Hematopoietic-Cell Lineages in Multiple MyelomaNew England Journal of Medicine, 1990
- Increase in the suppressor-inducer T cell subset in multiple myeloma and monoclonal gammopathy of undetermined significanceBritish Journal of Haematology, 1989
- Multiple myeloma: Relationship between light chain isotype suppression, labelling index of plasma cells, and CD38 expression on peripheral blood lymphocytesAmerican Journal of Hematology, 1988
- Selective loss of CD4+ CD45R+ T cells in peripheral blood of multiple myeloma patientsJournal of Clinical Immunology, 1988
- Cell surface expression of beta 2-microglobulin (beta 2m) correlates with stages of differentiation in B cell tumours.Journal of Clinical Pathology, 1987
- T‐cell subpopulations in patients with monoclonal gammopathies: Essential monoclonal gammopathy, multiple myeloma, and Waldenstrom macroglobulinemiaAmerican Journal of Hematology, 1985
- T Cells in Monoclonal GammopathiesScandinavian Journal of Haematology, 1982
- T‐Cell Subpopulations in Multiple Myeloma: Correlation with Clinical Disease StatusBritish Journal of Haematology, 1981